Abstract: An online system displays supplemental content in conjunction with messaging threads between users and third parties to promote clear and productive conversations. The online system enables third parties to specify a set of content items to be displayed within a messaging interface when a messaging thread is initiated with the third party by other users. The set of content items may include one or more of images, videos, or web pages. When a user initiates a messaging thread with a third party, the online system accesses the set of specified content items and generates a messaging interface including one or more of the specified content items. By incorporating the content items within the messaging interface, the online system enables users and third parties to communicate while interacting with and viewing the content items.

Abstract: A wavelength calibration method for a microring filter includes selecting N wavelengths from M wavelengths, and performing operations on the microring filter for each of the N wavelengths, thereby obtaining N sets of calibrated voltages, and obtaining, based on N sets of calibrated voltages, M?N sets of calibrated voltages corresponding to M?N wavelengths of the M wavelengths. The operating include adjusting thermal tuning power of the plurality of microrings in response to one set of voltages, and obtaining a plurality of sets of voltages that enable monitored optical power to have an extreme value, and using the plurality of sets of voltages as a reference, adjusting the thermal tuning power of the plurality of microrings in response to another set of voltages, and determining one of the N sets of calibrated voltages from the plurality of sets of voltages.

Abstract: A wavelength calibration method, apparatus, and system is disclosed. The method includes: selecting sonic wavelengths from a plurality of wavelengths, and performing the following operations on a microring filter for each of the some wavelengths, to obtain sets of calibrated voltages of the some wavelengths: (1) adjusting thermal tuning power of multiple microrings by using one set of voltages, and obtaining multiple sets of voltages that enable monitored optical power to have an extreme value, and (2) using the multiple of sets of voltages as a reference, adjusting the thermal tuning power of the multiple microrings by using another set of voltages, and determining one of the sets of calibrated voltages, which enables the monitored optical power to converge, from the multiple sets of voltages; and then, obtaining, through calculation based on the sets of calibrated voltages of the some wavelengths, sets of calibrated voltages of other wavelengths.

Abstract: The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel stereoselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.

Abstract: The distribution and/or ratio of Thymine, Cytosine, Adenine and Guanine of a DNA sequence from a target organism are organized and analyzed. The result is then used to determine the possible impacts the target organism may have in a host such as a human body. The corresponding treatment and prevention strategies may also be determined. The goal is to provide an effective way to diagnose, treat and prevent diseases such as infectious diseases, to test the safety of food and drugs, and therefore to create natural and effective solutions for health care and food supply. For example, a DNA analysis method configured according to the invention receives a DNA sequence input and converts it into a reassembled sequence. A result based on the reassembled sequence may then be output. Determination of the analysis result, treatment and prevention strategies may also be output.

Abstract: The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.

Abstract: Slag fiber is used to fabricate a friction material. Friction factor and abrasion loss of the friction material are controlled. The friction material can be used to make linings. Thus, slag fiber can be used as a replacement for natural material to make a friction material, and waste is thus recycled.

Abstract: Disclosed is a method for making fiber paper. In this method, mineral fibers and PVA resin are blended in water, thus forming first solution. Polymer fibers and PVA resin are blended in water, thus forming second solution. The first solution is mixed with the second solution. A wet paper-making machine is used to make mineral fiber paper from the mixture.

Abstract: A porous soundproof board is fabricated Recycled waste, like slag, is used for fabrication. Slag and ceramics are mixed to be poured into a network foam carrier. Then, the soundproof board is fabricated through sintering. Thus the board fabricated has great added values and is environmental protected with low cost.

Abstract: Disclosed is a method for making fiber paper. In this method, mineral fibers and PVA resin are blended in water, thus forming first solution. Polymer fibers and PVA resin are blended in water, thus forming second solution. The first solution is mixed with the second solution. A wet paper-making machine is used to make mineral fiber paper from the mixture.

Abstract: Slag fiber is used to fabricate a friction material. Friction factor and abrasion loss of the friction material are controlled. The friction material can be used to make linings. Thus, slag fiber can be used as a replace of natural material to make a friction material, and waste is thus recycled.

Abstract: The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.

Abstract: Incinerator ashes, which is obtained after treating municipal solid waste, incinerator ashes or its plasma vitrified slag is made into mineral fibers. Cullet is added during manufacturing the mineral fibers for conditioning. The mineral fibers thus obtained have a good strength and could raise value of recycled product. In addition, it could reduce impact of the incinerator ashes to the environment and environmental protection is achieved.

Abstract: The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.

Abstract: Methods are provided for depositing amorphous carbon materials. In one aspect, the invention provides a method for processing a substrate including forming a dielectric material layer on a surface of the substrate, depositing an amorphous carbon layer on the dielectric material layer by introducing a processing gas comprises one or more hydrocarbon compounds and an argon carrier gas, and generating a plasma of the processing gas by applying power from a dual-frequency RF source, etching the amorphous carbon layer to form a patterned amorphous carbon layer, and etching feature definitions in the dielectric material layer corresponding to the patterned amorphous carbon layer. The amorphous carbon layer may act as an etch stop, an anti-reflective coating, or both.

Abstract: This invention is directed to a protocol and design for an apparatus to analyze the distribution and/or ratio of Thymine, Cytosine, Adenine and Guanine of a DNA sequence from a target organism. The result is then used to determine the possible impact the target organism may have in a host such as a human body. The goal is to provide an effective way to diagnose diseases such as infectious diseases, to test the safety of food and drugs, and therefore to create natural and effective solutions for health care and food supply. For example, a DNA analysis method configured according to the invention receives a DNA sequence input and converts it into a reassembled sequence. A result based on the reassembled sequence may then be output.

Abstract: The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.

Abstract: Incinerator ashes, which is obtained after treating municipal solid waste, incinerator ashes or its plasma vitrified slag is made into mineral fibers. Cullet is added during manufacturing the mineral fibers for conditioning. The mineral fibers thus obtained have a good strength and could raise value of recycled product. In addition, it could reduce impact of the incinerator ashes to the environment and environmental protection is achieved.

Abstract: The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.

Abstract: A multilayer antireflective hard mask structure is disclosed. The structure comprises: (a) a CVD organic layer, wherein the CVD organic layer comprises carbon and hydrogen; and (b) a dielectric layer over the CVD organic layer. The dielectric layer is preferably a silicon oxynitride layer, while the CVD organic layer preferably comprises 70-80% carbon, 10-20% hydrogen and 5-15% nitrogen. Also disclosed are methods of forming and trimming such a multilayer antireflective hard mask structure. Further disclosed are methods of etching a substrate structure using a mask structure that contains a CVD organic layer and optionally has a dielectric layer over the CVD organic layer.